The	O
cancer	B-Cell
cell	I-Cell
'	O
s	O
"	O
power	O
plants	O
"	O
as	O
promising	O
therapeutic	O
targets	O
:	O
an	O
overview	O
.	O

This	O
introductory	O
article	O
to	O
the	O
review	O
series	O
entitled	O
"	O
The	O
Cancer	B-Cell
Cell	I-Cell
'	O
s	O
Power	O
Plants	O
as	O
Promising	O
Therapeutic	O
Targets	O
"	O
is	O
written	O
while	O
more	O
than	O
20	O
million	O
people	O
suffer	O
from	O
cancer	B-Cancer
.	O

It	O
summarizes	O
strategies	O
to	O
destroy	O
or	O
prevent	O
cancers	B-Cancer
by	O
targeting	O
their	O
energy	O
production	O
factories	O
,	O
i	O
.	O
e	O
.	O
,	O
"	O
power	O
plants	O
.	O
"	O
All	O
nucleated	O
animal	O
/	O
human	O
cells	B-Cell
have	O
two	O
types	O
of	O
power	O
plants	O
,	O
i	O
.	O
e	O
.	O
,	O
systems	O
that	O
make	O
the	O
"	O
high	O
energy	O
"	O
compound	O
ATP	O
from	O
ADP	O
and	O
P	O
(	O
i	O
)	O
.	O

One	O
type	O
is	O
"	O
glycolysis	O
,	O
"	O
the	O
other	O
the	O
"	O
mitochondria	B-Cellular_component
.	O
"	O
In	O
contrast	O
to	O
most	O
normal	O
cells	B-Cell
where	O
the	O
mitochondria	B-Cellular_component
are	O
the	O
major	O
ATP	O
producers	O
(	O
>	O
90	O
%	O
)	O
in	O
fueling	O
growth	O
,	O
human	O
cancers	B-Cancer
detected	O
via	O
Positron	O
Emission	O
Tomography	O
(	O
PET	O
)	O
rely	O
on	O
both	O
types	O
of	O
power	O
plants	O
.	O

In	O
such	O
cancers	B-Cancer
,	O
glycolysis	O
may	O
contribute	O
nearly	O
half	O
the	O
ATP	O
even	O
in	O
the	O
presence	O
of	O
oxygen	O
(	O
"	O
Warburg	O
effect	O
"	O
)	O
.	O

Based	O
solely	O
on	O
cell	B-Cell
energetics	O
,	O
this	O
presents	O
a	O
challenge	O
to	O
identify	O
curative	O
agents	O
that	O
destroy	O
only	O
cancer	B-Cell
cells	I-Cell
as	O
they	O
must	O
destroy	O
both	O
of	O
their	O
power	O
plants	O
causing	O
"	O
necrotic	O
cell	B-Cell
death	O
"	O
and	O
leave	O
normal	O
cells	B-Cell
alone	O
.	O

One	O
such	O
agent	O
,	O
3	O
-	O
bromopyruvate	O
(	O
3	O
-	O
BrPA	O
)	O
,	O
a	O
lactic	O
acid	O
analog	O
,	O
has	O
been	O
shown	O
to	O
inhibit	O
both	O
glycolytic	O
and	O
mitochondrial	B-Cellular_component
ATP	O
production	O
in	O
rapidly	O
growing	O
cancers	B-Cancer
(	O
Ko	O
et	O
al	O
.	O
,	O
Cancer	O
Letts	O
.	O
,	O
173	O
,	O
83	O
-	O
91	O
,	O
2001	O
)	O
,	O
leave	O
normal	O
cells	B-Cell
alone	O
,	O
and	O
eradicate	O
advanced	O
cancers	B-Cancer
(	O
19	O
of	O
19	O
)	O
in	O
a	O
rodent	O
model	O
(	O
Ko	O
et	O
al	O
.	O
,	O
Biochem	O
.	O
Biophys	O
.	O
Res	O
.	O
Commun	O
.	O
,	O
324	O
,	O
269	O
-	O
275	O
,	O
2004	O
)	O
.	O

A	O
second	O
approach	O
is	O
to	O
induce	O
only	O
cancer	B-Cell
cells	I-Cell
to	O
undergo	O
"	O
apoptotic	O
cell	B-Cell
death	O
.	O
"	O
Here	O
,	O
mitochondria	B-Cellular_component
release	O
cell	B-Cell
death	O
inducing	O
factors	O
(	O
e	O
.	O
g	O
.	O
,	O
cytochrome	O
c	O
)	O
.	O

In	O
a	O
third	O
approach	O
,	O
cancer	B-Cell
cells	I-Cell
are	O
induced	O
to	O
die	O
by	O
both	O
apoptotic	O
and	O
necrotic	O
events	O
.	O

In	O
summary	O
,	O
much	O
effort	O
is	O
being	O
focused	O
on	O
identifying	O
agents	O
that	O
induce	O
"	O
necrotic	O
,	O
"	O
"	O
apoptotic	O
"	O
or	O
apoptotic	O
plus	O
necrotic	O
cell	O
death	O
only	O
in	O
cancer	B-Cell
cells	I-Cell
.	O

Regardless	O
how	O
death	O
is	O
inflicted	O
,	O
every	O
cancer	B-Cell
cell	I-Cell
must	O
die	O
,	O
be	O
it	O
fast	O
or	O
slow	O
.	O

